Market Challenges And Opportunities

Global Abortion Drugs Market: Drivers

The abortion drugs market is expected to experience significant growth over the forecast period due to increasing abortion cases among women, globally. For instance, according to the Centers for Disease Control and Prevention, 623,471 abortion cases were reported in 2016. According to the same source, rate of abortion was 11.6 per 1,000 individual women who are in the age group of 15 to 44 years in 2016.

Furthermore, in 2016, new label for mifepristone medicine was approved by the U.S. Food and Drug Administration (FDA). Moreover, the U.S FDA approval of new label for mifepristone assures safety of medicine for all women.

Global Abortion Drugs Market: Restraints

However, side effects associated with the mifepristone drug for termination of pregnancy such as fever higher than 100.4 degree for longer than four hours, vomiting, nausea, diarrhea, and severe pelvic pain are major factors that restrain the global abortion drugs market growth.

Moreover, high cost associated with the mifepristone drug is another factor hampering the global abortion drugs market growth. For instance, cost of mifepristone drug is US$ 83.33 for every 200mg tablet in the U.S.

Furthermore, on March 24, 2020, Texas announced abortion as non-essential procedure to keep the valuable medical resources for treating COVID-19 patients only. it is mentioned that violators can be fined or jailed. As a result, the demand for abortion medicine is expected to decrease in the U.S.